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Abstract
Inherited defects in retinal photoreceptor structure impair visual transduction, disrupt relationship with the retinal pigment
epithelium (RPE), and compromise cell viability. A variety of progressive retinal degenerative diseases can result, and
knowledge of disease etiology remains incomplete. To investigate pathogenic mechanisms in such instances, we have
characterized rod photoreceptor and retinal gene expression changes in response to a defined insult to photoreceptor
structure, using the retinal degeneration slow (rds) mouse model. Global gene expression profiling was performed on flow-
sorted rds and wild-type rod photoreceptors immediately prior and subsequent to times at which OSs are normally
elaborated. Dysregulated genes were identified via microarray hybridization, and selected candidates were validated using
quantitative PCR analyses. Both the array and qPCR data revealed that gene expression changes were generally modest and
dispersed amongst a variety of known functional networks. Although genes showing major (.5-fold) differential expression
were identified in a few instances, nearly all displayed transient temporal profiles, returning to WT levels by postnatal day (P)
21. These observations suggest that major defects in photoreceptor cell structure may induce early homeostatic responses,
which function in a protective manner to promote cell viability. We identified a single key gene, Egr1, that was dysregulated
in a sustained fashion in rds rod photoreceptors and retina. Egr1 upregulation was associated with microglial activation and
migration into the outer retina at times subsequent to the major peak of photoreceptor cell death. Interestingly, this
response was accompanied by neurotrophic factor upregulation. We hypothesize that activation of Egr1 and neurotrophic
factors may represent a protective immune mechanism which contributes to the characteristically slow retinal degeneration
of the rds mouse model.
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Introduction
Human vision begins with rod and cone photoreceptors, light-
sensitive ciliated sensory neurons situated in the neural retina.
These fragile cells are susceptible to a variety of insults, which can
impede their function and viability and cause retinal degeneration
and vision loss. Vertebrate animal models, and in particular mice,
have been a valuable resource to identify molecules essential for
normal photoreceptor physiology. Although a wide variety of
naturally occurring and engineered mouse models have been
investigated for retinal degeneration [1], and a majority of vision
loss in inherited photoreceptor degenerations is known to result
from secondary pathogenic processes, the detailed mechanisms by
which genetic defects cause retinal degeneration continue to be
debated [2–5]. Further advances are needed to improve
understanding of normal photoreceptor physiology and implement
more effective clinical treatments. It is anticipated that insights into
the relatively simple monogenic diseases can simultaneously shed
light on widely prevalent loss-of-sight conditions with multifacto-
rial etiologies.
The retinal degeneration slow (rds) mouse (also known as Prph2
Rd2)
has been the focus of numerous investigations of photoreceptor
and retinal structure, function and viability [6–8]. This naturally
occurring model results from a spontaneous insertion of viral DNA
into the rds (also known as Prph2) gene to produce a null allele [9].
Complete loss of the gene product (peripherin/rds) in homozygous
null animals prevents elaboration of rod and cone photoreceptor
outer segments (OSs) – the specialized ciliary organelles upon
which vertebrate light detection depends [10]. Surprisingly, this
massive structural defect is not catastrophic for photoreceptor
viability. Instead, cells undergo a relatively slow rate of
degeneration that occurs over a period of months [11,12], and
has prompted evaluation of several therapeutic strategies [13–15].
A previous study applied a whole-retina microarray approach to
the rds model to identify genes associated with retinal degeneration
[16]. Here, we investigate the global transcriptome response of
purified rds rod photoreceptors to lack of peripherin/rds and
absence of OSs. Our findings suggest that a combination of
homeostatic mechanisms may contribute to the protracted time
course of retinal degeneration in the rds retina.
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Identification of differentially expressed genes in rds rod
photoreceptors
To investigate how inherited defects in photoreceptor structure
can affect cell viability, we adopted a flow-sorting method for
identifying transcriptome changes in rod photoreceptors [17]. We
applied this technique to the rds mouse retina, since this animal
model possesses a well-defined monogenic defect in photoreceptor
structure, and mutations in rds produce a broad spectrum of
human retinal disease [18,19]. Figure 1A illustrates the rationale
underlying our approach. OSs of murine rod photoreceptors
develop in the postnatal pup; their elaboration begins at ,P10,
they establish contact with the RPE by ,P14, and attain their full
length by ,P21. Although rds (2/2) photoreceptors differentiate
and establish otherwise normal morphology, they fail to elaborate
OSs, do not establish a normal relationship with the RPE, and
thereafter degenerate over a protracted time course [8]. To
document early gene expression changes in rods that fail to
elaborate OSs and attach to the RPE, we performed microarray
analyses of flow-sorted rod photoreceptors from young murine
retinas at times prior (P6, P9) and subsequent (P14, P21) to the age
at which OSs are normally elaborated (P10) [20].
Rod photoreceptors in a congenic line of rds (2/2) mice were
genetically labeled by transfer of a Nrl-eGFP transgene from an
established line [17]. We confirmed the transfer and retention of
the rds (2/2) phenotype by examination of retinal cryosections.
We observed that retinas from P14 WT, Nrl-eGFP, and rds:Nrl-
eGFP animals each expressed eGFP, as indicated by robust green
fluorescence in their outer nuclear layers (ONLs; Fig. 1B). This
result is consistent with the observation that the Nrl-GFP
transgene drives onset of GFP expression shortly after terminal
division and cell cycle exit of cells fated to be rods [17]. In contrast,
photoreceptor OSs were present in WT and Nrl-eGFP, but not
rds:Nrl-eGFP retinas - as assayed by anti-P/rds immunohisto-
chemistry (Fig. 1B). These results are consistent with a well-
documented lack of OSs in rds homozygotes [10].
P6, P14, and P21 retinas from Nrl-eGFP and rds:Nrl-eGFP
animals were enzyme dissociated, and GFP-labeled rods were
isolated by FACS. Figure 1B shows typical histograms of GFP-
based sorting of cell samples from each genotype; ,500,000 GFP-
positive cells were typically collected per retina and ,1 mg of total
RNA was obtained from one animal. Global gene expression in
processed samples was assessed by hybridization to Affymetrix
Gene chips; four to five biological replicates were assayed per
genotype at each time point. Array data was analyzed using two
way ANOVA, p-values were calculated using the Benjamini-
Haschberg method to control for the false discovery rate, with
limitations of p-value #0.05 and fold changes restricted to $2.0.
Using these criteria, a total of 1603 probes were observed to be
differentially regulated in the rds:Nrl-GFP rods at one or more
time points (Table S1). Genes exhibiting differential expression
were relatively rare at P6 (154) but increased with age; 725 and
1190 were identified at P14 and P21 respectively.
We used Ingenuity Pathway Analysis (IPA) to analyze the data
generated by expression profiling to determine affected cellular
functional pathways. IPA uses a curated database with structured
ontology to extract biological meaning from gene expression data.
The analysis identified functional pathways in which differentially
regulated genes were overrepresented (summarized in Table 1). A
relatively wide variety of functions were seen to be perturbed.
Some pathways, such as ‘‘cellular assembly and organization’’, and
‘‘cellular development’’ can be rationalized directly, given the loss
of an entire organelle, in the rds phenotype. Others, such as
‘‘genetic disorders’’, may reflect more broadly-based changes in
cellular biochemistry affecting the neuron-enriched cell population
used to generate the array data. Interestingly, temporal profiling of
the data reveals that few genes displayed sustained changes.
Validation of genes dysregulated in the rds retina
We evaluated a subset of differentially expressed genes
(identified by the microarray analysis) using Taqman assays to
perform quantitative PCR (qPCR). These experiments incorpo-
rated three biological replicates to provide high-confidence data,
and were conducted on intact retinas (vs. isolated rod photore-
ceptors) to eliminate the possibility that we would identify gene
expression changes induced by cell isolation procedures. More
than seventy genes with defined functions were chosen for analysis
at each of four time points (P6, P9, P14, P21). We used three
selection criteria and included genes that, 1) exhibited high-fold
changes (and small p-values) as assayed by microarray, 2) were
potential network partners for the high-fold changers, or 3) were
known to have roles in inherited retinal degenerations. Together,
they fell into five major functional pathways, including: transcrip-
tion factors, phototransduction pathway, lipid metabolism, cellular
organization, and cell adhesion (Figure 2).
These pathways likely represent alterations in cellular homeo-
stasis that result from a failure of P/rds expression and OS
formation. Interestingly, we found a number of characteristics that
were common across all the pathways. Firstly, gene expression
changes were generally modest; most (46%) were less than two-
fold. Secondly, higher-fold changers were dispersed across the five
pathways. Finally, changes in expression were only rarely
sustained with time. Interestingly, many genes exhibited a distinct
pattern of temporal gene expression changes with transient
differential expression observed at P14, in conjunction with little
or no change at either of the other three time points studied.
Figure 3 shows that ten (of the seventy) genes studied showed this
particular pattern - all were substantially upregulated at P14
(immediately following the time at which OS elaboration began),
but returned to baseline by P21. Six such genes are associated with
cellular organization (Dctn1, Dfnb31, Dnm1, Impdh1, Rpgr, Rpgrip1,)
and the other four participate in lipid homeostasis (Abcg1, Abcg4,
Plch2, Srebf1). In only two instances (Mef2C and Egr1), were
sustained changes in gene expression observed. Mef2c encodes a
transcription factor expressed in a variety of tissues [21]; recent
evidence suggests that it plays a role in rod homeostasis [22,23].
The sustained downregulation documented here may reflect
regulation by transiently decreased Nrl levels (Fig. 3). Egr1 (also a
transcription factor) action has been of substantial interest in a
wide variety of biological contexts, and its expression has been
documented in the vertebrate retina [24–27].
Figure 4A shows that Egr1 expression, as assayed both by gene
microarray of rod photoreceptors, and by qPCR of whole retinal
samples, steadily increased from P6 to P21 in response to the rds
defect. A maximal value of ,10-fold increase in gene expression
over WT retina was observed at P21. These results are intriguing
because Egr1 upregulation has been reported to occur in several
other models of inherited retinal disease [28,29]. In particular,
Egr1 is suggested to mediate microglial immune responses in
retinoschisin-deficient mice [28]. To investigate whether Egr1
upregulation also induces microglial activation in the rds model, we
assayed expression of microglia marker CD68 by qPCR. Figure 4B
shows that this gene was upregulated in a slightly delayed, though
temporally sustained fashion in the rds retina (maximally 3.5 fold at
P21). CD68 upregulation initiated slightly later than that of Egr1,
likely a reflection of microglial activation at stages subsequent to
the time OS are normally elaborated.
Protective Mechanisms in the RDS Mouse Retina
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Photoreceptors in the rds mouse fail to elaborate OSs. OS disk membrane biosynthesis begins at ,P10, OSs are well established by P14, and reach full
length by ,P21. (B) Left panels: immunofluorescence analyses of retinal cryosections; DAPI-stained nuclei appear blue. eGFP labeled photoreceptors
(green) were observed in WT, Nrl-eGFP and rds:Nrl-eGFP retinas; however, OSs labeled with anti-P/rds antibody PabMPCT (red), were only detected in
WT and Nrl-eGFP retinas. Right panels: fluorescence-activated cell sorting was utilized to enrich rod photoreceptors from trypsin-dissociated mouse
retinas. Typical histograms, generated using a BD Biosciences FACSVantage SE cell sorter, illustrate GFP-containing rod photoreceptors detected in
dissociated (P9) retinas from Nrl-eGFP and rds:Nrl-eGFP, but not WT mice. Collected rod cell fractions, typically ,500,000 cells per retina, are indicated
(brackets).
doi:10.1371/journal.pone.0031371.g001
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changes in genetic regulation, as a result of the rds defect.
Top functional pathways Genes p-values
Genetic disorder Abcg1, Itgb5, Srebf1, Marcks, Tulp1,Ttr, Crb1, Dmd, Gnb1, Cep290, Dctn1, Impdh1,
Rpgr, Smpd1, Dfnb31, Crx, Egr1, Gas7, Rorb
4.83E-07
Small molecule biochemistry Abcg1, Abcg4, Marcks, Plch2, Ptdss2, Smpd1, Srebf1, Gnb1, 7.68E-05
Cellular assembly and organization Marcks, Smpd1, Ttr, Cttn, Gnb1, Dctn1, Dnm1, Gas7 4.98E-05
Cellular development Itgb5, Marcks, Smpd1, Srebf1, Cttn, Dync1h1, Rpgr, Egr1, Gas7, Rorb, Crb1 5.88E-04
Lipid metabolism Abcg1, Abcg4, Plch2, Ptdss2, Smpd1 1.93E-03
This list was generated with input of all genes which are differentially regulated at one or more time points.
doi:10.1371/journal.pone.0031371.t001
Figure 2. Quantitative PCR analyses for validation of gene expression changes in the rds model. For each gene, the maximal fold change
value (rds:Nrl-eGFP vs. Nrl-eGFP) between P6 and P21 was plotted. Error bars indicate the standard error of the mean (s.e.m.; n=3). Genes were
classified into functional pathways, using Ingenuity Pathways Analysis software. Expression of most genes changed less than two-fold, and
dysregulation in a variety of functional pathways was seen.
doi:10.1371/journal.pone.0031371.g002
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We used an anti-Iba1 antibody to perform immunohistochemical
(IHC) labeling of filamentous (resting) and ameboid (activated/
migrating) microglia. We were particularly interested in document-
ing whether cells redistributed from INL to ONL, since this
criterion reflects an active immune response [30]. Both microglial
subtypes were observed in P9 WT and rds retina – prior to the stage
at which OSs are normally elaborated (Fig. 5A). Roughly similar
numbers and distributions of the subtypes were observed in the two
genotypes. The majority of Iba-1 positive cells were found in the
plexiform layers (IPL, OPL), although occasional examples were
observed in the INL as well. These observations are consistent with
a proposed role of microglia in phagocytosis of apoptotic debris
related to normal retinal development [31]. In contrast, by P14,
nearly all microglia exhibited resting phenotypes and were present
entirely within plexiform layers in each genotype. These distribu-
tions are expected for retinas that have completed developmentally-
related apoptosis. Finally, at P21, a clear difference was observed
between rds and WT retina. In particular, activated microglia were
present in the ONL of rds, but not WT retina (Fig. 5A). These
ameboid cells were present, both along the edge of, and deep within
the ONL - consistent with an immune response targeting this
region. To verify these findings, IHC labeling was repeated using
anti-Cd11b antibody, another commonly used marker for microg-
lia, and essentially similar results were obtained. Finally, GFAP, a
retinal stress marker which labels activated Mller glia, exhibited
only slight reactivity in rds P14, but robust labeling of cell processes
in rds P21. Altogether, the findings suggest that microglial migration
and activation occurs as part of a stress response to failed OS
elaboration.
A neuroprotective immune response in the rds retina
Although traditionally viewed as neurotoxic agents, activated
microglia have more recently been proposed to play a variety of
roles for neurons [32]. Since we observed significant microglial
activation after the peak of apoptotic photoreceptor cell death
(well documented to occur in rds at P17 [33,34]), it suggested the
possibility that these immune cells may mount a neuroprotective
response. To evaluate this idea, we assayed the expression of
cytokines, cytokine receptors and growth factors known to impact
photoreceptor viability. Figure 6 shows that neurotrophic factors
CNTF, GDNF, their receptors CNTFR and GFRA1, and TGF-b
were upregulated at least 2-fold in the developing rds retina. In
contrast, factors associated with microglial activation and sharply
upregulated prior to photoreceptor apoptosis [30,35], including
the proinflammatory cytokines IL6, IL10, and TNF-a, were
undetectable in the rds retina (not shown). Taken together, the
results suggest that microglial activation may contribute a
protective role for photoreceptor cell viability in the rds model.
Discussion
A wide variety of inherited defects in retinal proteins adversely
affect photoreceptor structure, disrupt the photoreceptor-RPE
Figure 3. Transient upregulation may reflect homeostatic
mechanisms. Differential regulation of numerous genes was observed
at P14; however, expression returned to baseline levels by P21. This
temporal pattern included genes mainly representing cellular organi-
zation and lipid metabolism functional pathways.
doi:10.1371/journal.pone.0031371.g003
Figure 4. Sustained gene expression changes for Egr1 and Cd68
genes in the rds retina. (A) Egr1 expression dysregulation is sustained
from P6 to P21, as assayed by gene microarray (black bars) and qPCR
(gray bars). This transcription factor has previously been proposed to
promote retinal degeneration via microglial activation. (B) qPCR assay of
CD68, a microglial marker, revealed a parallel, but delayed upregulation.
No data for CD68 was produced by microarray analysis. The combined
findings are indicative of microglial activation.
doi:10.1371/journal.pone.0031371.g004
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of visual function. Similar pathologies may also apply to more
complex diseases for which multifactorial genetic contributions are
present, such as age-related macular degeneration. Substantial
progress has been made cataloging the physiological consequences
of defined defects and modeling how such primary insults
adversely impact retinal health and vision [5]; however, current
understanding of the molecular, cellular, and tissue-level etiology
of progressive retinal degeneration remains relatively incomplete.
The aim of the present study was to investigate how rod
photoreceptor and retinal gene expression responds to a defined
structural defect – loss of the OS organelle.
The well-studied murine rds model represents a spontaneous
null mutation resulting from a viral insertion event into chromosome
17 [9]. Complete loss of the gene product, P/rds, leads to an initial
failure of OS elaboration and a loss of photoreceptor viability. The
primary structural phenotype can be rationalized in light of a
proposed scaffolding role for P/rds [7,8]. Apoptosis and
autophagy have been suggested to figure in the degenerative
process [33,36,37], although the protracted time course of disease
remains to be explained. We focused on early gene expression
changes in the rds model, during the period immediately prior and
subsequent to the normal time of OS elaboration, and employed a
flow-sorting approach to highlight responses of rod photoreceptor
cells. Ingenuity Pathways Analysis was applied to screen the
transcriptome data, and identified significant changes in five
functional pathways including: genetic disorders, small molecule
biochemistry, cellular assembly and organization, cellular devel-
opment, and lipid metabolism. We further analyzed the dataset
manually, seeking to identify concerted alterations in expression of
genes associated with photoreceptor function, viability, or
degeneration. In general however, gene dysregulation was
manifested as a broad pattern of transient and typically low-
amplitude gene expression changes across numerous functional
pathways.
Real-time qPCR validation experiments emphasized that gene
expression changes between P6 and P21 in the rds retina were
generally modest, transient, and dispersed over numerous
functional classes. This timespan includes the initiation (P14) and
peak (P17) of apoptotic photoreceptor cell death [33,37]. Previous
investigations of other murine models for retinal degeneration
have also documented small non-concerted changes in the gene
Figure 5. Activated microglia are present in mature rds retina. (A) Immunofluorescent micrographs of age-matched rds and WT murine ocular
cryosections are shown; DAPI-stained nuclei appear blue. Labeling of microglia by anti-Iba1 and anti-CD11b antibodies (red, left and middle panels)
shows distributions of resting filamentous (arrowheads) and activated ameboid (arrows) microglia. GFAP labeling (red, right panels) shows
distributions of activated Mu ¨ller glial cells and reflects retinal stress. (B) Quantitative analysis of activated microglial migration in rds (filled bars) and
WT (unfilled bars) retinas. Iba1 labeled cells were tabulated as described in Methods (averages are reported s.e.m.; n=3). The results show migration
of activated microglia into nuclear layers of the P21 rds retina.
doi:10.1371/journal.pone.0031371.g005
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The lack of dramatic and/or sustained alterations in gene
expression of rds can be rationalized in several ways. Firstly, the
one-hit model of Clarke, et al suggests that inherited defects can
affect disparate aspects of cellular physiology to bring photore-
ceptors closer to their viability threshold [39]. This may explain
why large-scale disruptions in gene regulation are not commonly
observed during the major phase of photoreceptor apoptosis.
Secondly, it is known that cell death pathways are often regulated
by post-transcriptional mechanisms [40]. Finally, since many (or
most) proteins exhibit multifunctionality and/or context-depen-
dent functions [41], it is conceivable that categorization of the
dysregulated genes into distinct networks merely reflects the
current state of knowledge. Thus, the genes identified here may
reflect a yet-to-be documented network, based on alternative
protein functions.
The few instances of large-scale gene dysregulation validated in
the present study were (with one exception) transient, and
clustered into three known pathways: genes associated with
cellular organization (Dctn1, Impdh1), lipid homeostasis (Abcg1,
Plch2), and photoreceptor-associated transcription (NRL, Mef2c,
Egr1). Dctn1 encodes a subunit of the macromolecular complex
dynactin, and participates in microtubule-based transport in
neurons [42]. Although not yet documented, it may play a similar
role for photoreceptors and respond to alterations in intraflagellar
transport caused by abrogated OS elaboration. Impdh1 has been
associated with instances of inherited retinal degeneration (RD10),
possibly by regulating rhodopsin expression [43]. This gene
product provides a clear example of protein multifunctionality – it
has been investigated for decades as a key enzyme for guanine
nucleotide biosynthesis; however, it also possesses an essential
context-dependent function for photoreceptors. Abcg1 and Plch2
are important for cholesterol and lipid metabolism and their
upregulation may represent a response to altered demands for
lipid production [44,45]. Finally, NRL and MEF2C are
transcription factors associated with rod photoreceptor develop-
ment and homeostasis. NRL is a key transcriptional regulator that
specifies photoreceptor cell fate [22,46,47]. Mef2c is recently shown
to be regulated by NRL and is likely important for photoreceptor
development and maintenance [21,23,48]. Importantly, nearly all
of the dysregulated genes returned to WT levels by P21. This
transient behavior may reflect homeostatic mechanisms that
function to maintain photoreceptor viability. A sustained alter-
ation of gene expression in the rds model was observed only for
Egr1, a ubiquitous zinc-finger transcription factor that participates
in a broad range of biological processes, including: cellular
proliferation and development [49], apoptosis [50,51], immune
response [30], and neuroplasticity [52]. This gene is differentially
expressed in several retinal cell types, but little consensus has been
reached regarding its role within photoreceptors and other
neurons [24,27,53,54]. Egr1 expression in retinal microglia has
been more thoroughly characterized, where it appears to
Figure 6. Neurotrophic factors are upregulated in the rds retina. Maximal Fold change values from qPCR study show strong upregulation of
CNTF and GDNF, which are known to have a neuroprotective role for photoreceptors. Error bars indicate standard error of the mean (n=3).
doi:10.1371/journal.pone.0031371.g006
Protective Mechanisms in the RDS Mouse Retina
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31371participate in the activation process [28,30,55] for these immune
system cells.
Egr1 has been implicated in several other murine models of
inherited retinal degeneration. Its early upregulation is proposed
to participate in immune responses that include microglial
activation in the rd1 [29] and retinoschisin knockout [28] mouse
retinas. In these models, Egr1 upregulation appears to promote
microglial cytotoxic activity that advances retinal degeneration
[35,55]. Although we observed Egr1 upregulation and microglial
activation in the rds retina, these events reached maximal levels
only subsequent to the peak of rds photoreceptor apoptosis, a time
course consistent with a previous study [34]. These findings
demonstrate that photoreceptor apoptosis in the rds model is at
least partially independent of Egr1-induced microglial activation.
Microglia have traditionally been viewed as cytotoxic; however,
more recent reports demonstrate that these cells can also perform
protective functions in a variety of tissues [31,56,57]. Along these
lines, we observed upregulation of several potent neurotrophins,
but not pro-inflammatory agents, during microglial infiltration. All
together, the results suggest the possibility that these cells play a
neuroprotective role for photoreceptors in the rds retina, and may
be helpful to consider for the design of therapeutic strategies for
related retinal dystrophies.
Materials and Methods
Animals
Procedures utilizing animals were in accordance to the
guidelines stipulated by Oakland University Animal Care and
Use Committee (IACUC #10061) as well as the ARVO
Statement for Use of Animals in Ophthalmic and Vision
Research. Animals were maintained at 22uC, with a 12 hour
fixed dark/light schedule and had unrestricted access to food and
water. Nrl-eGFP mice [17] were crossed onto a congenic line of rds
animals on the C57BL/6J background [58] to generate rds (2/2)
and rds (+/+) mice carrying the Nrl-eGFP transgene.
FACS Enrichment and Microarray Hybridization
Mice at indicated ages (P6, P9, P14, and P21) were sacrificed
by decapitation 2–3 hours subsequent to light onset. Retinas from
4–5 independent biological replicates were immediately dissected
from enucleated eyes, and dissociated with trypsin (1 mg/ml in
PBS) for 5 min at 37uC. Reactions were quenched with SBTI
(1 mg/ml), and GFP
+ cells were collected using a BD Biosciences
FACSVantage SE cell sorter, essentially as described [17]. Total
RNA was purified from pelleted cells (typically ,0.5610
6 GFP
+
events per retina) using a RNAqueous-4PCR kit (Ambion, Inc).
RNA samples were assayed spectrophotometrically for nucleotide
concentration via absorbance at 260 nm, and for quality using an
Agilent 2100 Bioanalyzer and RNA 6000 Nano LabChip.
Samples showing discrete rRNA bands at predicted mobilities
were processed for microarray expression analysis, using an
Ovation Biotin System v1.0 amplification kit (NuGEN Technol-
ogies, Inc), according to manufacturer’s protocol. Amplified
cDNAs from were hybridized to Mouse Genome 430 2.0 Array
GeneChips (Affymetrix Inc.) and detected, essentially as de-
scribed [59].
Microarray gene filtering and clustering
Microarray based gene expression profiling was performed as
described previously [17,60]. Four chips were used for each time
point (except P14 where three chips were used). Initial raw data
analysis was performed using Gene Spring GX 11.0.2 software
(Silicon Genetics, Redwood city CA). Gene Chip Robust Multi-
chip method (GCRMA) was used for data normalization, and
average mean was used for summarization. Fold changes are
reported as the log of reciprocal transformation of the expression
ratio. Statistical analysis of filtered genes to identify differential
expressed genes between WT and mutant at all time points was
done using two way ANOVA [17]. Benjamini-Hochberg method
was used for multiple testing correction with the false discovery
rate subject to p-value #0.05 and fold-changes $2.0. Ingenuity
Pathway Analysis (Ingenuity Systems, Redwood City, CA) was
used in conjunction with the gene lists to identify affected networks
and functional pathways. Microarray data, in compliance with
Minimum Information About a Microarray Experiment (MIAME)
guidelines have been deposited into the Gene Expression Omnibus
(GEO; accession number GSE33134).
Quantitative RT-PCR of acutely isolated retinas
Age and genotype appropriate mice were euthanized by
asphyxiation with CO2 and the retina were dissected out under
a stereomicroscope, snap-frozen, and immediately stored at
280uC, until further use. Total RNA was prepared using a
Absolutely RNA miniprep kit (Stratagene, Inc) as recommended
by the manufacturer. Concentration was determined spectropho-
tometrically and quality of the preparation was determined using
denaturing agarose gel electrophoresis. A Superscript first strand
synthesis system for RT-PCR kit (Invitrogen, Inc) was utilized to
prepare cDNA using 5.0 mg of total RNA.
Real-time PCR experiments were performed using Taqman
reagents from Applied Biosystems, as per manufacturer’s instruc-
tions. cDNA for a given sample was diluted 100-fold and 3 mlo f
the dilution was amplified in 20 ml reaction mixtures using a
Stratagene MxPro thermocycler. Two technical replicates and
three biological replicates were used for each reaction. Relative
expression levels were determined by normalizing to the GAPDH
cDNA present in individual samples and comparing the
normalized value to a standard curve. The standard curve was
made using three technical replicates of a dilution series of a
mixture of equal volumes of wild type samples for all time points.
Immunohistochemistry
Mice were sacrificed by asphyxiation with CO2 under normal
room illumination. The superior hemisphere of each eye was
marked, and the eyes were enucleated and placed into 4%
paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4.
The cornea and the lens were removed after an initial fixation of
30 min, and the eyecups were fixed further for 2 hrs. Subse-
quently the eye cups were cryoprotected in 20% sucrose/0.1 M
sodium phosphate buffer overnight and frozen in a solution
composed of 2:1 ratio of 20% sucrose in PBS and optimal cutting
temperature compound [61]. Cryosections (10 mm) were blocked
in 5% normal goat serum in 0.1 M PBS, 0.5% BSA, 0.2%
Tween-20, 0.05% sodium azide, pH 7.3 for 1 hr at RT. Sections
were labeled with primary antibodies Anti-rat Cd11b
(MCA711GT, AbD Serotec) at 1:200 dilution, Anti-rabbit GFAP
(Z0334, DAKO) at 1:1000 dilution, for 12 hrs at 4uC, washed,
then labeled with fluorescently-conjugated secondary antibodies
for 1.5 hrs at room temperature. Slides were washed, cover-
slipped, and imaged using epi-fluoresence microscopy at 406
magnification (Nikon Optiphot-2) using a SPOT digital camera.
Exposure time was set to a value just below saturation for the
most intensely labeled sample in an age-matched set, and
identical exposures were used for all samples within that set.
Selected GFAP images were adjusted (using Photoshop) to
highlight filamentous labeling.
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Table S1 Gene expression profiles of rds:Nrl-eGFP rod
photoreceptors purified from mouse retina at P6, P14
and P21, as determined by Affymetrix GeneChip
hybridizations. Fold-changes are reported as the log reciprocal
transformation of the expression ratio. 1603 genes with F.C of
$2.0 and p-value #0.05 were dysregulated at one or more time
points.
(XLS)
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